太原肛门处潮湿(太原拉粑粑带血) (今日更新中)

A 3-year-old girl goes out to dinner with her family, and decides to pick up the check.The problem? Her credit card is fake.This is what the little girl handed a waiter at a Carabba's in Indiana - a fake pink credit card. 22-year-old Wendell Davenport decided to play along. Not only taking her card, but drawing a receipt for her, and putting her check in its own folder.The girl's family appreciated what the waiter did, and left him an additional tip along with the toddler's signed receipt. 502

....John a loser and swear on whatever, or whoever, I was asked to swear on, that I never called our great fallen soldiers anything other than HEROES. This is more made up Fake News given by disgusting & jealous failures in a disgraceful attempt to influence the 2020 Election!— Donald J. Trump (@realDonaldTrump) September 4, 2020 343

(KGTV) -- Many scientists and doctors are cautiously optimistic about taking a step forward in the fight against COVID-19 after encouraging news from Pfizer Monday.Pfizer announced that early data revealed its vaccine was more than 90 percent effective in protecting trial participants against the coronavirus.The U.S. Federal Food and Drug Admiration still needs to review the drug for safety and efficacy, and Pfizer plans to seek an Emergency Use Authorization this month, but regardless some see this as a good sign for other vaccine trials.“I think this is frankly the break we’ve all been waiting for, and I hope we have many others to follow,” said Dr. Susan Little, a UC San Diego Professor of Medicine.UCSD is participating in Phase 3 clinical trials for Moderna, AstraZeneca, and Janssen vaccines.Little leads the AstraZeneca and Janssen trials, which resumed locally last week.“I think what this means for all of the trials that are available at this stage, this is incredibly good news,” she said. “So far, they all use the same approach to vaccine development; they are all targeting the same protein, the spike protein, on the coronavirus.”She expects similar results to come from Moderna’s early data sometime this year.“The Pfizer and the Moderna both use the same vaccine platform, the same structure for their vaccine construct, so there’s every reason to be very optimistic the Moderna study might show similar results,” she said. “While the AstraZeneca and the Janssen use a different vaccine construct, they both are targeting the same protein.”If Pfizer’s vaccine is approved, it could be given to healthcare workers and high-risk populations in just months, and the general population in 2021, according to Pfizer.Pfizer said it expects to produce 50 million vaccine doses globally in 2020 and up to 1.3 billion in 2021.Pfizer’s CEO, Albert Bourla, said he expects the vaccine to be free of charge for Americans. 1943

“Today I'm donating convalescent plasma,” Judy Lutkin said.“This will be my third time donating.” Lutkin had COVID-19 back in April. “I was pretty sick for about four or five days,” she said. Now she comes infrequently to donate plasma. “It doesn't hurt. It doesn't feel bad. It’s fairly easy.”Plasma is just one of the tools used in fighting coronavirus. As it gets donated, it goes to COVID patients.Since early April, when Vitalant started collecting these donations, they’ve collected more than 9,700 donations equaling more than 33,000 units.“You could help as many as five patients with one sitting,” Liz Lambert, Vitalant spokesperson, said.Vitalant is a nonprofit that collects blood for about 1,000 hospitals across the country.“Right now, there's an emergency need for convalescent plasma as we anticipate more patients will be getting that treatment, or hospitals will be wanting to use that treatment,” Lambert said.The FDA issued an emergency use authorization for convalescent plasma as a potential COVID-19 treatment in late August. Convalescent plasma is taken from the blood of someone who’s already contracted a particular illness, in this case, COVID-19.This isn’t the first time in history; it’s been used to treat a virus.“Convalescent plasma is a very historic and crude way of conferring so-called passive immunity to patients who have a viral or bacterial disease,” Doctor Phil Stahel, Chief Medical Officer at the Medical Center of Aurora, said.So far, this center has treated 100 COVID-19 patients using this method.“Studies have shown that convalescent plasma is very safe,” he said. “It has been recently used for Ebola and other viral diseases for which we do not have a vaccination.”Doctor Stahel said patients they treat who are significantly sick could recover within 24 to 48 hours.Here’s how it works.“Antibodies are proteins that we form in our blood that attack antigens once our immune system recognizes them. It takes weeks for these to develop,” Doctor Ralph Vassallo, Chief Medical & Scientific Officer for Vitalant, said.The antibodies are taken from a recovered patient and put in a patient who recently contracted the disease.“The idea of convalescent plasma is to give them, in that period, when the patient does not have their immune response, to help neutralize the virus and prevent it from infecting cells in the body,” Doctor Vassallo said. “Convalescent plasma has been used for over 100 years in respiratory infections, including influenza.”With more hospitals using convalescent plasma to help COVID-19 patients, blood donation centers hope to identify more plasma donors who have recovered from the virus.“Whether its blood or convalescent plasma, there is a constant need,” Lambert said.Vitalant checks every regular blood donor for the antibodies as well, in hopes of identifying more possible donors.“In the first couple of September, it’s been about 3.6% nationwide,” Dr. Vassallo said.Those interested in donating convalescent plasma need to meet the same requirements as a blood donor, like being 16 years old or older, and at least 110 pounds.However, they also need to have a doctor-referred case of COVID-19 or doctor-referred antibody test.“It is indeed the first line of defense, and we should treat those patients early. This is for the adult in patients who are severely sick and at risk of getting on a ventilator, which we try to avoid by all means,” Doctor Stahel said. 3450

(KGTV) — Navy officials say the San Diego-based aircraft carrier USS Theodore Roosevelt is searching for a Sailor overboard off Southern California's coastline Thursday.The ship started rescue efforts after a lookout spotted what they believed to be a person in the water at about 7:30 a.m., according to the Navy. The Navy says one Sailor was unaccounted for during a command-wide roll call. The Sailor's parents identified him as 20-year-old Aviation Ordnanceman Airman Apprentice Ethan Goolsby of San Antonio, Texas, Scripps affiliate KSAT reports. The Navy has not officially identified the missing Sailor.Three search and rescue helicopters and a Rigid Hull Inflatable Boat were launched to assist.The U.S. Coast Guard, U.S. Navy aircraft, USS Bunker Hill, USS Russell, USS Howard, and USS Charleston are also helping in the search and rescue efforts. The Navy says search efforts will continue through Thursday night.No further information about the search efforts was immediately released.The USS Theodore Roosevelt departed San Diego just days ago for a sustainment exercise ahead of its second deployment this year, according to USNI News. The ship is set to change its homeport from San Diego to Bremerton, Wash., for an overhaul in 2021. 1256

来源：资阳报